• Publication Slide

  • sale

  • USA

  • welcome

  • slide_1

Quanta BioDesign

Quanta BioDesign is a research and manufacturing company committed to the development of a full range of discrete polyethylene glycol (dPEG®) PEGylation reagents for applications in diagnostics, therapeutics, peptide synthesis, oligonucleotide synthesis, and nanotechnology.

Quanta BioDesign’s vision incorporates a dedicated commitment to producing the most useful compounds for your current and future applications and needs using synthetic and process technology that allows the most economic incorporation of these products into your application.

PEGS 2014

May 5 – 9, 2014
Booth # 217
World Trade Center Boston
Boston, MA

TIDES 2014

May 12 – 15, 2014
Booth # 323
Rhode Island Convention Center
Providence, RI

BIOCONJUGATES

June 4 – 6, 2014
Grand Hyatt Hotel
San Francisco, CA